Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression
胶质母细胞瘤对EGFR抗体药物偶联物的耐药性是由转录重编程和TEK诱导的EGFR抑制驱动的。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07216-5
Blomquist, Mylan R; Noviello, Teresa M R; Sereduk, Christopher; Grief, Dustin; Caruso, Francesca P; Sharma, Ritin; Garcia-Mansfield, Krystine; Pirrotte, Patrick; Kloss, Jean; D'Angelo, Fulvio; Marin, Bianca M; Porath, Kendra; Jain, Sonia; Rabichow, Benjamin; Ensign, Shannon P Fortin; Iavarone, Antonio; Paladino, Antonella; Sarkaria, Jann N; Loftus, Joseph C; Ceccarelli, Michele; Tran, Nhan L